Alector, Inc. (ALEC)
1.945
+0.10
(+5.71%)
USD |
NASDAQ |
Oct 19, 15:05
Alector Profit Margin (Quarterly) : -692.5% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -692.5% |
| March 31, 2026 | -2.19K% |
| December 31, 2025 | -597.5% |
| September 30, 2025 | -1.06K% |
| June 30, 2025 | -387.7% |
| March 31, 2025 | -1.10K% |
| December 31, 2024 | -3.82% |
| September 30, 2024 | -275.2% |
| June 30, 2024 | -256.4% |
| March 31, 2024 | -227.0% |
| December 31, 2023 | -272.8% |
| September 30, 2023 | -488.3% |
| June 30, 2023 | 2.45% |
| March 31, 2023 | -277.1% |
| December 31, 2022 | -363.1% |
| September 30, 2022 | -310.7% |
| June 30, 2022 | 12.38% |
| Date | Value |
|---|---|
| March 31, 2022 | -182.3% |
| December 31, 2021 | -397.4% |
| September 30, 2021 | 69.40% |
| June 30, 2021 | -839.6% |
| March 31, 2021 | -1.27K% |
| December 31, 2020 | -1.08K% |
| September 30, 2020 | -892.7% |
| June 30, 2020 | -1.43K% |
| March 31, 2020 | -558.1% |
| December 31, 2019 | -508.7% |
| September 30, 2019 | -1.18K% |
| June 30, 2019 | -355.1% |
| March 31, 2019 | -331.1% |
| December 31, 2018 | -190.0% |
| June 30, 2018 | -156.4% |
| March 31, 2018 | -171.5% |
| December 31, 2017 | -319.6% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -237.8% |
| Oncolytics Biotech, Inc. | -- |
| Sangamo Therapeutics, Inc. | -2.15K% |
| Sarepta Therapeutics, Inc. | -1.22% |
| Anixa Biosciences, Inc. | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -368.4% |
| Return on Assets | -41.27% |
| Return on Invested Capital | -172.9% |
| Gross Profit Margin (Quarterly) | 38.28% |
| Operating Margin (Quarterly) | -731.7% |
| Return on Net Operating Assets | -463.2% |